Takeda Escapes Antitrust Suit Over IBS Drug

By Julie Manganis · November 21, 2023, 2:38 PM EST

A Massachusetts federal judge on Monday tossed a Blue Cross affiliate's proposed class action against Takeda Pharmaceuticals over an alleged conspiracy to keep generic versions of constipation drug Amitiza off the...

To view the full article, register now.